PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
50.37
ESG score below 80% of RNAZ's 63.21. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
43.48
Environmental score below 80% of RNAZ's 55.41. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
55.43
Social score 80-90% of RNAZ's 67.22. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
52.20
Governance score below 80% of RNAZ's 67.01. Jim Chanos would check for potential agency conflicts and oversight failures.